Board members of Scandinavian ChemoTech fully subscribe to the current issue
Members of Scandinavian ChemoTech's board have chosen to fully subscribe to the ongoing rights issue. These subscription commitments are in addition to previously communicated commitments and the subscription made by the Company's major owner and CEO Mohan Frick and his family of approximately SEK 2 million.Through these subscription commitments, the board once again shows its trust and foundational faith in Scandinavian ChemoTech and the Company's future prospects. For more information, please contact: Mohan Frick, CEO +46 (0)10-218 93 00 ir@chemotech.se